# Company Intelligence Dossiers - Top 10 Outreach Targets

*Research compiled January 2026*

---

## 1. OpenEvidence ($12B) - PubMed API

### Company Overview
- **Valuation:** $12B (Jan 2026, Series D)
- **Total Funding:** $700M in <1 year
- **Description:** "ChatGPT for doctors" - AI medical search engine used by 40%+ of US physicians
- **Headquartered:** Massachusetts

### Recent News (Last 3 Months)
- **Jan 2026:** Raised $250M Series D at $12B valuation (doubled in 3 months)
- **Oct 2025:** $200M Series C at $6B, led by Google Ventures
- **Jul 2025:** $210M round led by GV and Kleiner Perkins
- **Partnership with Veeva Systems** for Open Vista initiative
- **Spoke at J.P. Morgan Healthcare Conference 2026** on "medical superintelligence"
- **TIME100 Most Influential People in Health 2025** - Daniel Nadler named

### Pain Points & Tech Needs
- **Heavy PubMed usage** - they need real-time clinical evidence synthesis
- **Multi-AI agentic architecture** - massive R&D and compute investments
- **Staying current with medical literature** - Nadler quotes "9 hours/day just to read top 10 journals"
- Uses **Baseten** for inference (mentioned in recent press release)
- Building "subspecialist AI agents" per clinical area

### Decision Maker: Daniel Nadler, PhD (Founder & CEO)
**Recent Activity:**
- **Sequoia Training Data Podcast** (Nov 2025) - discussed OpenEvidence vision
- **CNBC Squawk on the Street** (Nov 2025) - medical AI investment dividends
- **No Priors Podcast** with Sarah Guo & Elad Gil (Sep 2025)
- Active on **LinkedIn** with product updates
- Previously founded Kensho (sold to S&P Global for $550M)

### Key Investors (Warm Intro Angles)
- **Sequoia Capital** (Pat Grady led Series A)
- **Google Ventures** (led Series C)
- **NVIDIA**
- **Kleiner Perkins**
- **Mayo Clinic** (strategic investor)
- **Thrive Capital, DST Global** (led Series D)
- **Craft Ventures** (David Sacks)

### Competitors They Watch
- Abridge, Hippocratic AI, Ambience Healthcare
- Elicit, Consensus (research synthesis)
- Any clinical decision support tools

### Actionable Hooks for Outreach
1. **"Saw your JP Morgan talk on medical superintelligence"** - shows you follow the space
2. **Reference the 9-hours-per-day reading problem** they're solving
3. **Mention PubMed API reliability for real-time evidence** - their core infrastructure need
4. **TIME100 Health recognition** - validates their impact

---

## 2. Glean ($7.2B) - Wikipedia API

### Company Overview
- **Valuation:** $7.2B (Jun 2025, Series F)
- **Total Funding:** $800M+ across 6 rounds
- **ARR:** Doubling past $100M
- **Employees:** 1,100+
- **Description:** Enterprise AI search & work assistant connecting all company data

### Recent News (Last 3 Months)
- **Jan 2026:** Partnership with **Virtue AI** for security platform for AI agents
- **Dec 2025:** Arvind Jain spoke at **Goldman Sachs Builders & Innovators Summit**
- **"Context graphs" as trillion-dollar opportunity** - Dec 2025 blog post by Jain
- **Glean:GO AI assistant** launching on Snowflake's AI Hub
- **Integration with Vercel v0** for AI-generated apps

### Pain Points & Tech Needs
- **Search accuracy** - 70%+ users report dissatisfaction per 2025 survey
- **Knowledge discovery bottleneck** - employees spend 1/3 of time searching
- **Multi-model approach** - uses various LLMs, needs reliable external data
- **Vendor lock-in concerns** from customers (competitor opportunity)
- **Slow rollouts** - enterprises want "days-to-value, not months"

### Decision Maker: Arvind Jain (Founder & CEO)
**Recent Activity:**
- **Economic Times podcast** (Dec 2025) - ET In The Valley
- **Goldman Sachs talk** (Oct 2025) - Transforming Work Productivity
- **Bg2 Pod** (Dec 2025) with Ali Ghodsi - "AI automation harder than expected"
- **Sequoia Training Data Podcast** (Nov 2025)
- **Fast Company Innovation Festival** (Sep 2025)
- **HumanX Amsterdam** speaker 2026
- Previously: Distinguished Engineer at Google

### Key Investors (Warm Intro Angles)
- **Sequoia Capital**
- **Kleiner Perkins**
- **Lightspeed Venture Partners**
- **General Catalyst**
- **IVP**
- **Wellington Management** (led Series F)
- **Khosla Ventures, DST Global, Coatue**
- **Capital One Ventures, Citi** (strategic)

### Competitors They Watch
- Coveo, Elastic Enterprise Search
- GoSearch, CustomGPT, Guru
- Hebbia (finance-focused)
- Microsoft Copilot, Notion AI

### Actionable Hooks for Outreach
1. **"Your context graph vision is spot on"** - reference Dec 2025 blog
2. **Goldman Sachs summit talk** - shows you follow exec activity
3. **Wikipedia for company knowledge enrichment** - general reference data layer
4. **"Employees spending 1/3 time searching"** - cite their own problem statement

---

## 3. Cohere ($6.8B) - ArXiv + Wiki

### Company Overview
- **Valuation:** $6.8B
- **Description:** Enterprise-focused LLM provider, embeddings leader (Nils Reimers)
- **Positioning:** Independent, cloud-agnostic, privacy-focused alternative to OpenAI

### Recent News (Last 3 Months)
- **Jan 2026:** Launched **Model Vault** for enterprise AI infrastructure
- **Jan 2026:** Strong **Davos 2026** presence - security & sovereign AI messaging
- **Dec 2025:** Partnership with **ThyssenKrupp Marine Systems** for Canadian submarine AI
- **May 2025:** Acquired **Ottogrid** (enterprise research automation)
- **Embed 4 multimodal** now on AWS Bedrock and Oracle OCI

### Pain Points & Tech Needs
- **Privacy, customization, integration** are their enterprise selling points
- **Legal challenges** similar to other AI vendors
- **Perception of being "behind"** in model race vs OpenAI/Anthropic
- **Embeddings accuracy concerns** - some benchmarks show lower scores
- Pivoting to **enterprise/government ecosystem development**

### Decision Maker: Nils Reimers (VP Embeddings)
**Why Nils vs CEO:**
- Directly owns embeddings product line
- Created **Sentence Transformers** (most-used embedding library)
- Technical decision-maker for embedding infrastructure
- Previously researcher at Ubiquitous Knowledge Processing Lab

### Key Investors (Warm Intro Angles)
- **NVIDIA**
- **Salesforce Ventures**
- **Oracle**
- **Tiger Global**
- **Index Ventures**

### Competitors They Watch
- OpenAI (text-embedding-3-large)
- Voyage AI (MongoDB partnership beating them on benchmarks)
- Gemini embeddings
- Jina AI

### Actionable Hooks for Outreach
1. **Sentence Transformers legacy** - compliment Nils's open-source impact
2. **Model Vault launch** - reference their enterprise infrastructure focus
3. **ArXiv for staying current on research** - they need to track competitor papers
4. **Sovereign AI positioning** - government clients need reliable data sources

---

## 4. Hippocratic AI ($3.5B) - PubMed API

### Company Overview
- **Valuation:** $3.5B (Nov 2025, Series C)
- **Total Funding:** $320M+ across Series A-C
- **Description:** Safety-first healthcare AI agents for patient calls, clinical support
- **Scale:** 150M+ clinical interactions, 8.95/10 satisfaction rating

### Recent News (Last 3 Months)
- **Jan 2026:** Acquired **Grove AI** (agentic AI for pharma R&D)
- **Jan 2026:** Partnership with **Huron Consulting Group**
- **Jan 2026:** Partnership with **BCG** for life sciences AI agents
- **Nov 2025:** $126M Series C led by Avenir Growth
- **Jan 2025:** $141M Series B led by Kleiner Perkins, unicorn status
- **Expanding across providers, payors, life sciences, government**

### Pain Points & Tech Needs
- **Clinical safety is paramount** - "do not diagnose or prescribe"
- **Polaris safety constellation architecture** - 30+ supporting LLMs
- **Medical literature accuracy** - critical for any healthcare AI
- **Regulatory compliance** in life sciences
- Addressing **staffing crisis** in healthcare

### Decision Maker: Munjal Shah (Co-Founder & CEO)
**Recent Activity:**
- **NVIDIA AI Podcast** (Jun 2025) - AI agents expanding healthcare capacity
- **a16z Bio + Health Podcast** (Jan 2025) - "Super Staffing" with Julie Yoo
- **Fixing Healthcare Podcast** (Feb 2025) - staffing crisis solutions
- **Fireside Chat** (Mar 2025) - physician-approved AI agents
- Previously: Founded Like.com (sold to Google), Riya
- Stanford CS background, neural networks for protein binding

### Key Investors (Warm Intro Angles)
- **Andreessen Horowitz (a16z)** - Bio + Health team
- **General Catalyst**
- **Kleiner Perkins** (led Series B)
- **NVIDIA (NVentures)**
- **CapitalG** (Google growth fund)
- **Avenir Growth** (led Series C)
- **Mayo Clinic** advisor network overlap with OpenEvidence

### Competitors They Watch
- Abridge, Ambience Healthcare (ambient documentation)
- OpenEvidence (clinical decision support)
- TigerConnect, Olive AI

### Actionable Hooks for Outreach
1. **"150M clinical interactions is remarkable scale"** - cite their own stats
2. **Grove AI acquisition** - shows life sciences expansion
3. **Polaris safety architecture** - needs reliable data for multi-LLM system
4. **a16z podcast on super staffing** - reference their thesis

---

## 5. LangChain ($1.25B) - Wiki + ArXiv

### Company Overview
- **Valuation:** $1.25B (Oct 2025, Series B)
- **Total Funding:** $260M
- **Description:** Open-source framework for AI agent orchestration (LangChain, LangGraph, LangSmith)
- **Employees:** ~100

### Recent News (Last 3 Months)
- **Jan 2026:** Newsletter highlighted agent observability & evals with LangSmith
- **Oct 2025:** $125M Series B led by IVP
- **Oct 2025:** LangGraph Platform GA for managed agent infrastructure
- **May 2025:** LangGraph Platform launched
- **Feb 2024:** LangSmith closed-source observability platform launched

### Pain Points & Tech Needs
- **Documentation quality** - frequently criticized as lagging/inconsistent
- **"Bloated and overly abstracted"** - common developer complaint
- **Debugging difficulty** - error messages point to framework internals
- **Dependency bloat** - separate packages for each model provider
- **Breaking API changes** - frequent compatibility issues

### Decision Maker: Harrison Chase (CEO & Co-Founder)
**Recent Activity:**
- **Sequoia Training Data Podcast** (Nov 2025) - orchestration layer for AI agents
- **Andrew Ng fireside chat** at Interrupt 2025 conference
- **Google Cloud Podcast** (Mar 2025) - AI agents and future of work
- **LinkedIn active** - hiring posts, product updates
- **Three Years of LangChain reflection** (Oct 2025 blog)
- "Context Engineering is the New AI Moat" - recent theme

### Key Investors (Warm Intro Angles)
- **Sequoia Capital**
- **Benchmark** (early seed investor)
- **IVP** (led Series B)
- **CapitalG** (new in Series B)
- **Datadog, Databricks** (strategic)
- **ServiceNow Ventures, Workday Ventures**

### Competitors They Watch
- LlamaIndex (RAG-focused competitor)
- CrewAI, AutoGPT (agent frameworks)
- Haystack, FlowiseAI
- Direct API usage (many devs skip frameworks now)

### Actionable Hooks for Outreach
1. **"Context engineering" thesis** - his new focus area
2. **Interrupt 2025 conference** - shows you follow their events
3. **ArXiv for research papers in RAG pipelines** - framework users need academic data
4. **Wikipedia for general knowledge grounding** - common RAG use case

---

## 6. Together AI ($3.3B) - ArXiv

### Company Overview
- **Valuation:** $3.3B (Feb 2025, Series B)
- **Total Funding:** $534M
- **Description:** AI Acceleration Cloud for open-source model training/inference
- **Customers:** 500K+ developers, enterprises like Zoom, Quora

### Recent News (Last 3 Months)
- **Feb 2025:** $305M Series B led by General Catalyst and Prosperity7
- **Forbes India profile** (Jun 2025) - "Democratizing AI access"
- **RAISE Summit 2025** speaker (Jul 2025)
- **Bloomberg TV interview** (Feb 2025)

### Pain Points & Tech Needs
- **Open-source model training** - needs research paper access
- **Research contributions** - they publish models and datasets
- **Competing with hyperscalers** on inference cost
- **Frontier research tracking** - ArXiv is core to their R&D

### Decision Maker: Vipul Ved Prakash (CEO & Co-Founder)
**Recent Activity:**
- **RAISE Summit 2025** presentation (Jul 2025)
- **Bloomberg TV** interview (Feb 2025)
- **Grit Podcast with Kleiner Perkins** (#200)
- Previously: Founded Cloudmark (anti-spam), Topsy (sold to Apple for $200M+)
- Software engineer and serial entrepreneur

### Key Investors (Warm Intro Angles)
- **General Catalyst** (co-led Series B)
- **Prosperity7** (Aramco Ventures, co-led)
- **Kleiner Perkins** (Bucky Moore)
- **Salesforce Ventures**
- **NVIDIA**
- **Emergence Capital**

### Competitors They Watch
- Fireworks AI, Anyscale
- Modal, Replicate
- Hyperscalers (AWS, GCP, Azure)
- Hugging Face

### Actionable Hooks for Outreach
1. **"Democratizing AI" mission** - aligns with open-source APIs
2. **RAISE Summit talk** - shows you follow their conference presence
3. **ArXiv for training data and research** - they literally train on papers
4. **Topsy/Apple acquisition background** - Vipul knows exits

---

## 7. Perplexity ($18-20B) - Wiki + ArXiv

### Company Overview
- **Valuation:** $18-20B (Dec 2025)
- **Total Funding:** $1.5B+
- **Monthly Queries:** 400M+ (Mar 2025)
- **Monthly Users:** 22M+ active
- **Description:** AI-powered search engine with cited sources

### Recent News (Last 3 Months)
- **Jan 2026:** $750M cloud deal with Microsoft Azure
- **Dec 2025:** Latest $200M funding round
- **Oct 2025:** Launched **Comet** AI browser
- **Sep 2025:** Launched **Search API** for developers
- **Aug 2025:** $34B bid to acquire Google Chrome (speculative)
- **Agentic AI** features in enterprise product

### Pain Points & Tech Needs
- **Real-time web indexing** - tens of thousands of index updates/second
- **Source accuracy** - reputation depends on cited sources
- **On-device AI threat** - Aravind warns about data center disruption
- **Content licensing disputes** - legal challenges with publishers

### Decision Maker: Aravind Srinivas (CEO & Co-Founder)
**Recent Activity:**
- **CNBC full interview** (Oct 2025) - Comet browser launch
- **NYT Hard Fork podcast** (Aug 2025) - Chrome acquisition bid
- **Lex Fridman Podcast** (#434)
- **Stanford GSB** talk (Oct 2025)
- **Forbes India** - youngest billionaire profile
- Previously: OpenAI, DeepMind research

### Key Investors (Warm Intro Angles)
- **Jeff Bezos** (Bezos Expeditions)
- **NVIDIA**
- **SoftBank Vision Fund 2**
- **IVP, NEA**
- **Mirae Asset** ($110M)
- **Nat Friedman** (ex-GitHub CEO)
- **Tobias Lütke** (Shopify CEO)

### Competitors They Watch
- Google (obviously)
- OpenAI ChatGPT with web browsing
- You.com, Brave Search
- Microsoft Copilot

### Actionable Hooks for Outreach
1. **Comet browser launch** - major recent product
2. **Microsoft deal** - shows enterprise scale
3. **"Processing 400M queries"** - cite NVIDIA spotlight
4. **Wikipedia and ArXiv for source grounding** - core to their product

---

## 8. Abridge ($2.75B) - PubMed

### Company Overview
- **Valuation:** $2.75B (Feb 2025, Series D)
- **Total Funding:** $778M across 8 rounds
- **Description:** Ambient AI for clinical documentation, "Linked Evidence" approach
- **Scale:** 100+ health systems, enterprise-wide at UPMC

### Recent News (Last 3 Months)
- **Jan 2026:** Partnership with **Availity** for payer-provider synergy
- **Jan 2026:** Uses **Baseten** for inference (same as OpenEvidence)
- **Jun 2025:** $316M Series E led by IVP
- **Feb 2025:** $250M Series D co-led by Elad Gil and IVP

### Pain Points & Tech Needs
- **Auditable AI** - maps summaries to ground truth ("Linked Evidence")
- **Medical accuracy** - reputation depends on clinical correctness
- **EHR integration** - UPMC enterprise deployment
- **Payer-provider workflows** - Availity partnership focus

### Decision Maker: Dr. Shiv Rao (CEO & Co-Founder)
**Recent Activity:**
- **Baseten quote** (Jan 2026) - "run models the way we need"
- **Availity partnership announcement** (Jan 2026)
- **Practicing cardiologist at UPMC** - unique clinical credibility
- Co-founded Abridge from Pittsburgh

### Key Investors (Warm Intro Angles)
- **Lightspeed Venture Partners** (led Series C)
- **IVP** (co-led Series D & E)
- **Elad Gil** (co-led Series D)
- **NVIDIA (NVentures)**
- **CVS Health Ventures** (strategic)
- **Kaiser Permanente Ventures**
- **Mass General Brigham AIDIF**

### Competitors They Watch
- Ambience Healthcare
- Nuance/Microsoft DAX
- Suki AI
- OpenEvidence (adjacent)

### Actionable Hooks for Outreach
1. **Practicing cardiologist** - Shiv's unique background
2. **Linked Evidence approach** - their differentiation
3. **UPMC enterprise-wide** - Pittsburgh success story
4. **Same Baseten infrastructure as OpenEvidence** - common pattern

---

## 9. Insitro ($2.4B) - PubMed

### Company Overview
- **Valuation:** ~$2.4B
- **Total Funding:** $643M+ (plus ~$150M non-dilutive pharma partnerships)
- **Description:** AI-driven drug discovery using ML + automated lab systems
- **Partners:** Bristol-Myers Squibb, Eli Lilly, Gilead

### Recent News (Last 3 Months)
- **Jan 2026:** Acquiring **CombinAbleAI** (Israel-based antibody design)
- **Jan 2026:** Presented at **J.P. Morgan Healthcare Conference 2026**
- **Dec 2025:** Appointed **Stephen Hitchcock** (R&D veteran) and **Vijay Pande** (a16z) as scientific advisors
- **Expanding globally:** US, Poland, Malaysia, Israel

### Pain Points & Tech Needs
- **Drug discovery data** - genomics, in vitro models, experimental data
- **Scientific literature synthesis** - need PubMed for research context
- **Causal biology** - their core thesis
- **Clinical trial data** - regulatory pathway needs

### Decision Maker: Daphne Koller, PhD (Founder & CEO)
**Recent Activity:**
- **J.P. Morgan Healthcare Conference 2026** presenter
- **Fortune Leadership Next podcast** (Jul 2025)
- **Stanford Medicine podcast** (Mar 2025) - AI in drug discovery
- **World Economic Forum** speaker
- **Coursera co-founder** - education tech pioneer
- **Stanford professor**, MacArthur Genius Fellow
- **Weights & Biases Gradient Dissent podcast** (Dec 2025)

### Key Investors (Warm Intro Angles)
- **Andreessen Horowitz (a16z)** - Vijay Pande connection
- **GV (Google Ventures)**
- **Foresite Capital**
- **ADS Ventures**
- **Pharma partners:** BMS, Lilly, Gilead

### Competitors They Watch
- Recursion Pharmaceuticals
- Insilico Medicine
- Schrödinger
- BenevolentAI

### Actionable Hooks for Outreach
1. **J.P. Morgan 2026 presentation** - recent high-profile event
2. **CombinAbleAI acquisition** - shows M&A appetite
3. **Vijay Pande as advisor** - a16z bio connection
4. **PubMed for drug discovery literature** - core research need

---

## 10. Pinecone ($750M) - Wikipedia

### Company Overview
- **Valuation:** $750M (Apr 2023 - may be considering sale/new round)
- **Total Funding:** $138M+
- **Description:** Managed vector database for AI applications
- **Positioning:** "Memory layer for AI"

### Recent News (Last 3 Months)
- **Sep 2025:** **Edo Liberty stepped down as CEO** to become Chief Scientist
- **Sep 2025:** **Ash Ashutosh** (ex-Google) appointed new CEO
- **Oct 2025:** Edo spoke at **TechCrunch Disrupt 2025**
- **Aug 2025:** Reports of **potential sale** amid rising competition
- Focus on **search infrastructure > bigger models** thesis

### Pain Points & Tech Needs
- **Rising competition** from Weaviate, Chroma, Milvus, Qdrant
- **Vector DB commoditization** - integrated into existing databases
- **Leadership transition** - Edo to Chief Scientist
- **Enterprise differentiation** needed

### Decision Maker: Edo Liberty (Founder & Chief Scientist) / Ash Ashutosh (CEO)
**Edo Liberty Recent Activity:**
- **TechCrunch Disrupt 2025** keynote (Oct 2025)
- **Unite.AI interview** (Sep 2025) on role transition
- **VentureBeat exclusive** on CEO transition
- Previously: Head of Amazon AI Labs
- Israeli R&D background

### Key Investors (Warm Intro Angles)
- **Andreessen Horowitz** (Peter Levine led Series B)
- **Menlo Ventures** (Tim Tully)
- **ICONIQ Growth**
- **Wing Venture Capital**

### Competitors They Watch
- Weaviate, Qdrant, Milvus, Chroma
- pgvector (PostgreSQL)
- MongoDB Atlas Vector Search
- Elastic vector search

### Actionable Hooks for Outreach
1. **TechCrunch Disrupt keynote** - "search > bigger models"
2. **Leadership transition** - new CEO means new opportunities
3. **Wikipedia for knowledge enrichment** - common vector DB use case
4. **Peter Levine (a16z)** - board member connection

---

## Cross-Company Insights

### Common Investors (Warm Intro Leverage)
| Investor | Companies |
|----------|-----------|
| Sequoia Capital | OpenEvidence, Glean, LangChain |
| a16z | Hippocratic, Pinecone, Insitro |
| General Catalyst | Glean, Hippocratic, Together AI |
| Kleiner Perkins | OpenEvidence, Glean, Hippocratic |
| NVIDIA | OpenEvidence, Hippocratic, Abridge, Together, Perplexity, Cohere |
| IVP | Glean, LangChain, Perplexity, Abridge |
| Lightspeed | Glean, Abridge |

### Healthcare AI Cluster
OpenEvidence, Hippocratic AI, Abridge, Insitro share:
- Same investor networks (a16z, NVIDIA, healthcare VCs)
- Same conferences (JP Morgan Healthcare)
- Similar PubMed needs
- **Angle:** "Your peers at [X] are already using our PubMed API"

### Research/Search Cluster
Perplexity, Cohere, LangChain, Together AI share:
- ArXiv paper needs
- Research-to-production pipelines
- Open-source sensibilities
- **Angle:** "ArXiv access for staying on the frontier"

### Enterprise AI Cluster
Glean, Pinecone, LangChain share:
- Enterprise search/retrieval focus
- Wikipedia for knowledge grounding
- RAG architecture dependencies
- **Angle:** "Reliable external knowledge for RAG"
